Our research is driven by the aim of developing “one shot” eye therapies suitable for curing blinding or fatal eye diseases in low resource settings. With this in mind, we concentrate on developing
Professor Christopher Layton, Clinical Director of the LVF, today welcomed Ms Naushene Sial to the LVF Eye Research Centre team, as she embarks on her PhD journey, delving into the untreatable aspects of Age-Related Macular Degeneration (AMD). Having completed her…
Recently the work by our scientific research team was selected for The Australasian Society for Stem Cell Research (ASSCR) early-career researcher symposium. This was held on 10 July at the Institute for Molecular Bioscience, The University of Queensland. Dr Brenda…
Gene therapies offer the possibility of long-lasting treatment for challenging and untreatable diseases, including genetic and non-genetic ones. Adeno-associated viruses (AAV) are delivery vehicles widely used in gene therapies, given their ability to deliver genes efficiently and safely to a…
Dr Brenda Castro, Scientific Fellow, LVF Ophthalmology Research Centre presented a poster at the XXV Biennial Meeting of the International Society for Eye Research (ISER), Gold Coast on 19-23 February 2023. The International Society for Eye Research (ISER), provides a…
Slawomir Andrzejewski had great success in April with international publication of his first manuscript in the prestigious journal "Gene Therapy", published by Nature. His research, which was all performed at the Layton Vision Foundation in Brisbane, describes progress towards permanent…
After an astounding seven presentations at the annual European Association for Vision and Eye Research (EVER) conference in Nice, 2017, two of our scholars, Aparna Murali and Dr Sean Jenkins, received awards for their work from the Association.
The European Association for Research in Vision and Ophthalmology has awarded Gabriela de Moraes, a scholar working in the Ophthalmology Research Unit, a prestigious prize for best presentation at their annual meeting in a field of 596, and she received a cash award of 500 euros for her work on mechanisms of macular blindness.
Sean is a postdoctorate clinical researcher in the Ophthalmology Research Unit working under A/Professor Layton’s supervision. He trained in scientific approaches to medical problems in Canada and Australia, completing a science degree with honours at the University of Toronto, a Masters of Health Economics at the University of Queensland and a Masters of Ophthalmology at the University of Sydney.